Bioptimus is developing a universal AI foundation model specifically for biological research, enabling researchers to leverage large-scale data analysis and predictive modeling. This technology addresses the challenge of slow and fragmented discovery processes in biomedicine by providing a cohesive platform for accelerating insights and innovations.
Funding
$76M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.





Founders
Product
Problem
The process of biological research and drug discovery is often slow and fragmented due to the complexity of biological data and the lack of integrated tools for analysis and prediction. Researchers face challenges in leveraging large-scale, multimodal datasets to gain comprehensive insights into biological systems and accelerate biomedical innovations.
Solution
Bioptimus is developing a universal AI foundation model designed to accelerate biological research and drug discovery. By training on massive amounts of biological and multimodal data, the platform aims to capture complex biological relationships and provide a holistic understanding of biological systems. The AI model offers researchers a cohesive platform to analyze data, generate predictions, and accelerate insights in biomedicine and environmental science. The platform leverages best-in-class GPUs and a scalable, secure computing environment to train and serve its foundation models.
Target Audience
The primary target audience includes research scientists, biomedical companies, and environmental science organizations seeking to accelerate their discovery processes and gain deeper insights from biological data.
Features
- AI foundation model trained on diverse, multimodal, and multiscale biological data
- Scalable and secure computing environment utilizing high-performance GPUs
- Enhanced data security measures for safe access, analysis, and management of vast datasets
- H-optimus-1: A state-of-the-art foundation model for pathology